Health & Biotech
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Rhythm Biosciences.
RELATED STOCKHEAD STORIES
Health & Biotech
China is about to grant patents like never before, and these ASX stocks have already got some
Health & Biotech
Check Up: Rhythm plans TGA submission and pig tissue MOU fails to impress
Health & Biotech
ASX Health Stocks: Noxopharm gets initial nod for patent, Rhythm tops 11pc on imminent market launch
Health & Biotech
ASX Health Stocks: Pharmaxis progresses to Phase 2 study on bone marrow cancer
Health & Biotech
ScoPo’s Powerplays: Market volatility creates both buying and selling opportunities in the Health sector
Health & Biotech
Rhythm Biosciences stock climbs, as coloSTAT achieves key milestone in goal to transform colorectal cancer diagnosis
Director Trades
Directors’ Trades: Otto Buttula buys another $580k of Rhythm Biosciences shares
Health & Biotech
ASX Health Stocks: NeuroScientific soars 10pc on COVID-19 drug, Telix advances prostate cancer studies
Health & Biotech
ScoPo’s Powerplays: Solid earnings for health stocks all round, but price action stays with larger caps
IPO Watch
IPO Watch: There’s another company seeking to detect cancer using blood tests listing on the ASX next week
News
Market highlights and 5 ASX small caps to watch on Thursday
Health & Biotech
ScoPo’s Powerplays: ‘Prepare for a big jump in July’ as tax-loss selling in healthcare continues
News
Last Orders: ASX teeters on the edge of 7,400
News
Market highlights and 5 ASX small caps to watch on Wednesday
Experts
ScoPo’s Powerplays: Hearing tech, medical devices to ride out choppy market
News
Last Orders: Resources and energy keep ASX in green territory
Health & Biotech